Edition:
United Kingdom

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

119.85USD
20 Jun 2018
Change (% chg)

$0.59 (+0.49%)
Prev Close
$119.26
Open
$119.26
Day's High
$120.17
Day's Low
$118.33
Volume
9,382
Avg. Vol
20,737
52-wk High
$128.25
52-wk Low
$93.59

Chart for

About

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical... (more)

Overall

Beta: 0.66
Market Cap(Mil.): $4,626.61
Shares Outstanding(Mil.): 40.51
Dividend: --
Yield (%): --

Financials

  TARO.N Industry Sector
P/E (TTM): 11.65 30.95 32.74
EPS (TTM): 9.81 -- --
ROI: 19.76 14.84 14.38
ROE: 19.80 16.34 16.08

BRIEF-Taro Pharmaceutical Industries Posts Q3 Earnings Per Share $0.45

* ‍EXCLUDING IMPACT OF ONE-TIME TAX RE-MEASUREMENT, EARNINGS PER SHARE FOR QUARTER WOULD BE $1.37​ Source text for Eikon: Further company coverage:

07 Feb 2018

BRIEF-Bellus Health Receives Milestone Payment From Taro Pharmaceuticals

* BELLUS HEALTH RECEIVES MILESTONE PAYMENT FROM TARO PHARMACEUTICALS Source text for Eikon: Further company coverage:

09 Jan 2018

Earnings vs. Estimates